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is believed to play an important role in the process of myelination in 
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with a priori hypotheses can be used to avoid the burden of correcting 
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currently enrolled participants have completed.
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Clinical history was recorded by the study neurologist with addiŊ
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predicts progression to relapse and annualized change 
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MBP variant may modify myelination and demyelination remains unŊ
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There are several potential caveats to our findings. By their naŊ
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dation of our findings in other longitudinal cohorts is essential.
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